Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease
Erin D. Michos, John W. McEvoy, Roger S. Blumenthal
New England Journal of Medicine (2019) Vol. 381, Iss. 16, pp. 1557-1567
Closed Access | Times Cited: 291

Showing 1-25 of 291 citing articles:

Gut microbiota in human metabolic health and disease
Yong Fan, Oluf Pedersen
Nature Reviews Microbiology (2020) Vol. 19, Iss. 1, pp. 55-71
Open Access | Times Cited: 3252
How the immune system shapes atherosclerosis: roles of innate and adaptive immunity
Payel Roy, Marco Orecchioni, Klaus Ley
Nature reviews. Immunology (2021) Vol. 22, Iss. 4, pp. 251-265
Open Access | Times Cited: 337
Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders
Daniel M. Chopyk, Arash Grakoui
Gastroenterology (2020) Vol. 159, Iss. 3, pp. 849-863
Open Access | Times Cited: 321
Mechanistic Insights into the Oxidized Low-Density Lipoprotein-Induced Atherosclerosis
Chainika Khatana, Neeraj K. Saini, Sasanka Chakrabarti, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-14
Open Access | Times Cited: 314
Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism
Arash Haghikia, Friederike Zimmermann, P. A. Schumann, et al.
European Heart Journal (2021) Vol. 43, Iss. 6, pp. 518-533
Open Access | Times Cited: 226
Fate and State of Vascular Smooth Muscle Cells in Atherosclerosis
Joseph M. Miano, Edward A. Fisher, Mark W. Majesky
Circulation (2021) Vol. 143, Iss. 21, pp. 2110-2116
Open Access | Times Cited: 205
Hallmarks of cardiovascular ageing
Mahmoud Abdellatif, Peter P. Rainer, Simon Sedej, et al.
Nature Reviews Cardiology (2023) Vol. 20, Iss. 11, pp. 754-777
Closed Access | Times Cited: 122
Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE
Prakriti Gaba, Michelle L. O’Donoghue, Jeong‐Gun Park, et al.
Circulation (2023) Vol. 147, Iss. 16, pp. 1192-1203
Closed Access | Times Cited: 98
Breaking tolerance: the autoimmune aspect of atherosclerosis
Amir Khan, Payel Roy, Klaus Ley
Nature reviews. Immunology (2024) Vol. 24, Iss. 9, pp. 670-679
Closed Access | Times Cited: 21
Dysregulated cellular metabolism in atherosclerosis: mediators and therapeutic opportunities
Chad Stroope, Felix Sebastian Nettersheim, Brian G. Coon, et al.
Nature Metabolism (2024) Vol. 6, Iss. 4, pp. 617-638
Open Access | Times Cited: 21
Advancements in risk stratification and management strategies in primary cardiovascular prevention
Fotios Barkas, Yusuf Ziya Şener, Pelin Golforoush, et al.
Atherosclerosis (2024) Vol. 395, pp. 117579-117579
Closed Access | Times Cited: 18
Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline
Connie B. Newman, Michael J. Blaha, Jeffrey B. Boord, et al.
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 12, pp. 3613-3682
Open Access | Times Cited: 105
LDL-C: lower is better for longer—even at low risk
Peter E. Penson, Matteo Pirro, Maciej Banach
BMC Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 100
ACC/AHA lipid guidelines: Personalized care to prevent cardiovascular disease
Cara Reiter–Brennan, Albert D. Osei, S.M. Iftekhar Uddin, et al.
Cleveland Clinic Journal of Medicine (2020) Vol. 87, Iss. 4, pp. 231-239
Open Access | Times Cited: 85
Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia
Gerald F. Watts, David Sullivan, David L. Hare, et al.
Heart Lung and Circulation (2020) Vol. 30, Iss. 3, pp. 324-349
Open Access | Times Cited: 81
Distribution of lipid levels and prevalence of hyperlipidemia: data from the NHANES 2007–2018
Zhenhan Li, Guoqi Zhu, Guo Chen, et al.
Lipids in Health and Disease (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 59
Risk factors mediating the effect of body mass index and waist-to-hip ratio on cardiovascular outcomes: Mendelian randomization analysis
Dipender Gill, Verena Zuber, Jesse Dawson, et al.
International Journal of Obesity (2021) Vol. 45, Iss. 7, pp. 1428-1438
Open Access | Times Cited: 57
Anti-atherosclerotic therapies: Milestones, challenges, and emerging innovations
Isabella Hetherington, Hana Totary-Jain
Molecular Therapy (2022) Vol. 30, Iss. 10, pp. 3106-3117
Open Access | Times Cited: 57
Unlocking the mysteries of VLDL: exploring its production, intracellular trafficking, and metabolism as therapeutic targets
Jingfei Chen, Zhenfei Fang, Qin Luo, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
ROS-Induced Endothelial Dysfunction in the Pathogenesis of Atherosclerosis
Ruiyi Yan, Xiao Zhang, Wenlong Xu, et al.
Aging and Disease (2024)
Open Access | Times Cited: 9
Haematometabolism rewiring in atherosclerotic cardiovascular disease
Laurent Yvan‐Charvet, Thibault Barouillet, Coraline Borowczyk
Nature Reviews Cardiology (2025)
Closed Access | Times Cited: 1
Metagenomic analysis of the gut microbiome in atherosclerosis patients identify cross‐cohort microbial signatures and potential therapeutic target
Sheng Liu, Wenjing Zhao, Xueyan Liu, et al.
The FASEB Journal (2020) Vol. 34, Iss. 11, pp. 14166-14181
Closed Access | Times Cited: 61
Advances in biological therapies for dyslipidemias and atherosclerosis
Eftaxia-Konstantina Valanti, Katerina Dalakoura-Karagkouni, Gerasimos Siasos, et al.
Metabolism (2020) Vol. 116, pp. 154461-154461
Closed Access | Times Cited: 55
Acetaldehyde Dehydrogenase 2 regulates HMG-CoA reductase stability and cholesterol synthesis in the liver
Shanshan Zhong, Luxiao Li, Ningning Liang, et al.
Redox Biology (2021) Vol. 41, pp. 101919-101919
Open Access | Times Cited: 53
Anthocyanin supplementation at different doses improves cholesterol efflux capacity in subjects with dyslipidemia—a randomized controlled trial
Zhongliang Xu, Jiewen Xie, Hanyue Zhang, et al.
European Journal of Clinical Nutrition (2020) Vol. 75, Iss. 2, pp. 345-354
Open Access | Times Cited: 52
Page 1 - Next Page

Scroll to top